KolovouVTsipisAMihasC. Tumor protein p53 (TP53) gene and left main coronary artery disease. Angiology. 2018;69:730–35.
2.
KhanSPhulukdareeARamkaranPMoodleyDChuturgoonAA. The Arg72 variant of the p53 functional polymorphism (rs1042533) is associated with coronary artery disease in young South Africans of Indian ancestry. Gene. 2016;593:261–4.
3.
Gloria-BottiniFBanciMSaccucciPNeriABottiniEMagriniA. p53 codon 72 polymorphism and coronary artery disease: evidence of interaction with ACP1. Med Sci Monit. 2012;18:CR712–5.
4.
ParaskevasKIMikhailidisDPVeithFJ. Patients with peripheral arterial disease, abdominal aortic aneurysms and carotid artery stenosis are at increased risk for developing lung and other cancers. Int Angiol. 2012;31:404–5.
5.
ParaskevasKIMikhailidisDPVeithFJ. Regarding “Estimating the risk of solid organ malignancy in patients undergoing routine computed tomography scans after endovascular aneurysm repair”. J Vasc Surg. 2012;56:1829.
6.
ArcidiaconoBIiritanoSNoceraA. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174.
7.
CoweySHardyRW. The metabolic syndrome: a high-risk state for cancer?Am J Pathol. 2006;169:1505–22.
8.
ParaskevasKITzovarasAABrianaDDMikhailidisDP. Emerging indications for statins: a pluripotent family of agents with several potential applications. Curr Pharm Des. 2007;13:3622–36.
9.
ParaskevasKIMikhailidisDPVeithFJSpenceJD. Definition of best medical treatment in asymptomatic and symptomatic carotid artery stenosis. Angiology. 2016;67:411–9.
10.
ParaskevasKIVeithFJLiapisCDMikhailidisDP. Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an update. Curr Vasc Pharmacol. 2013;11:112–20.
11.
ParaskevasKIAthyrosVGBrianaDDKakafikaAIKaragiannisAMikhailidisDP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Curr Drug Targets. 2007;8:942–51.
